Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7786158 | 0.97 | TTR (0.38) | TTRCHRNB4CHRNA3KCNA3HTR2A | |
| SCHEMBL7794866 | 0.97 | SSTR2 (0.37) | TTRKCNA3HTR2AHTR2CHTR2B | |
| SCHEMBL7791970 | 0.97 | TTR (0.39) | TTRCHRNB4CHRNA3KCNA3CHRNB2 | |
| SCHEMBL7792331 | 0.96 | KCNA3 (0.40) | CHRNB4CHRNA3KCNA3HTR2AHTR2C | |
| SCHEMBL7792023 | 0.96 | KCNA3 (0.40) | CHRNB4CHRNA3KCNA3HTR2AHTR2C | |
| SCHEMBL7791842 | 0.95 | TTR (0.39) | TTRCHRNB4CHRNA3KCNA3CHRNB2 | |
| SCHEMBL7792135 | 0.94 | TTR (0.37) | TTRKCNA3HTR2AHTR2CHTR2B | |
| SCHEMBL7794727 | 0.94 | TTR (0.39) | TTRKCNA3 | |
| SCHEMBL7786316 | 0.93 | CHRNB4 (0.42) | TTRCHRNB4CHRNA3KCNA3 | |
| SCHEMBL7786122 | 0.93 | KCNA3 (0.39) | KCNA3HTR2AHTR2CHTR2BELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0906268-B1 | ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS | AVENTIS PHARMA INC (US) | 2001-11-28 | — | — | EP | disclosed |
| US-6004959-A | HYPOTENSIVE, ANTITUMOR, ANTIINFLAMMATORY AND ANTIASTHMATIC AGENTS; ANGIOGENESIS AND ALVEOLAR MACROPHAGE ACTIVATION INHIBITORS | HOECHST MARION ROUSSEL, INC. (US) | 1999-12-21 | — | — | US | disclosed |